Treatment of proliferative vitreoretinopathy using aerosolized methotrexate

Ended Project Grant Awarded Last action

Award ID
R41EY030819
Recipient
Awarding agency
Obligated
$336,954

Award facts

Assistance listing
93.867 Vision Research
Completion date
Originally
Place of performance
Minnesota, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Original award $336,954

Quick answers

Who received award R41EY030819?

R41EY030819 was awarded to Abbe Vision Inc. by National Eye Institute (National Institutes of Health) on July 1, 2020.

How much is award R41EY030819 worth?

$336,954 has been obligated on R41EY030819.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award